United Therapeutics Corporation (UTHR)


United Therapeutics Corporation (UTHR)

$81.31 USD

0.51 (-0.62%)

Updated Aug 20 4:00pm

Add UTHR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

UTHR Daily Price Range
UTHR 52-Week Price Range

UTHR Stock Chart More Charts


UTHR Price/Volume Stats

Current price $81.31
Prev. close $81.82
Day low $80.69
Day high $82.48
50-day MA $78.88
200-day MA $101.61
52-week high $129.59
52-week low $74.31
Volume 245,398
Avg. volume 553,152
Dividend yield N/A
Market Cap 3.57B

United Therapeutics Corporation (UTHR) Company Bio


United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.





UTHR News Stream


Event/Time News Detail
Loading, please wait...

UTHR Social Stream


Loading social stream, please wait...

View Full UTHR Social Stream

UTHR Returns

1-mo 7.95%
3-mo -6.59%
6-mo -30.52%
1-year -34.97%
3-year -35.94%
5-year -13.27%
YTD -25.34%
2018 -26.39%
2017 3.15%
2016 -8.42%
2015 20.94%
2014 14.51%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4359 seconds.